(Reuters) – Drugmakers partnered with the U.S. government are on track to begin actively manufacturing a vaccine for the COVID-19 virus by the end of the summer, a senior administration official said on Monday.
The U.S. government has helped finance the development of several vaccines and therapies through its Operation Warp Speed program and plans to announce more investments in COVID-19 vaccines in the future, the official said.
(Reporting by Carl O’Donnell in New York)
